These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38787640)

  • 1.
    Rainha J; Rodrigues JL; Rodrigues LR
    ACS Synth Biol; 2024 Jun; 13(6):1727-1736. PubMed ID: 38787640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curcumin biosynthesis from ferulic acid by engineered Saccharomyces cerevisiae.
    Rainha J; Rodrigues JL; Faria C; Rodrigues LR
    Biotechnol J; 2022 Mar; 17(3):e2100400. PubMed ID: 34882970
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Li Y; Mao J; Liu Q; Song X; Wu Y; Cai M; Xu H; Qiao M
    ACS Synth Biol; 2020 Apr; 9(4):756-765. PubMed ID: 32155331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of curcuminoids from tyrosine by a metabolically engineered Escherichia coli using caffeic acid as an intermediate.
    Rodrigues JL; Araújo RG; Prather KL; Kluskens LD; Rodrigues LR
    Biotechnol J; 2015 Apr; 10(4):599-609. PubMed ID: 25641677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. De novo resveratrol production through modular engineering of an Escherichia coli-Saccharomyces cerevisiae co-culture.
    Yuan SF; Yi X; Johnston TG; Alper HS
    Microb Cell Fact; 2020 Jul; 19(1):143. PubMed ID: 32664999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reconstructing curcumin biosynthesis in yeast reveals the implication of caffeoyl-shikimate esterase in phenylpropanoid metabolic flux.
    Utomo JC; Barrell HB; Kumar R; Smith J; Brant MS; De la Hoz Siegler H; Ro DK
    Metab Eng; 2024 Mar; 82():286-296. PubMed ID: 38387678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. De novo production of resveratrol from glucose or ethanol by engineered Saccharomyces cerevisiae.
    Li M; Kildegaard KR; Chen Y; Rodriguez A; Borodina I; Nielsen J
    Metab Eng; 2015 Nov; 32():1-11. PubMed ID: 26344106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineering de novo anthocyanin production in Saccharomyces cerevisiae.
    Levisson M; Patinios C; Hein S; de Groot PA; Daran JM; Hall RD; Martens S; Beekwilder J
    Microb Cell Fact; 2018 Jul; 17(1):103. PubMed ID: 29970082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineering and systems-level analysis of Saccharomyces cerevisiae for production of 3-hydroxypropionic acid via malonyl-CoA reductase-dependent pathway.
    Kildegaard KR; Jensen NB; Schneider K; Czarnotta E; Özdemir E; Klein T; Maury J; Ebert BE; Christensen HB; Chen Y; Kim IK; Herrgård MJ; Blank LM; Forster J; Nielsen J; Borodina I
    Microb Cell Fact; 2016 Mar; 15():53. PubMed ID: 26980206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of Curcuminoids in
    Kim EJ; Cha MN; Kim BG; Ahn JH
    J Microbiol Biotechnol; 2017 May; 27(5):975-982. PubMed ID: 28274102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. De novo biosynthesis of pterostilbene in an Escherichia coli strain using a new resveratrol O-methyltransferase from Arabidopsis.
    Heo KT; Kang SY; Hong YS
    Microb Cell Fact; 2017 Feb; 16(1):30. PubMed ID: 28202018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-Level Production of Hydroxytyrosol in Engineered
    Liu H; Wu X; Ma H; Li J; Liu Z; Guo X; Dong J; Zou S; Luo Y
    ACS Synth Biol; 2022 Nov; 11(11):3706-3713. PubMed ID: 36345886
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Liu Y; Song D; Hu H; Yang R; Lyu X
    ACS Synth Biol; 2022 Sep; 11(9):3067-3077. PubMed ID: 35952699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic engineering and transcriptomic analysis of Saccharomyces cerevisiae producing p-coumaric acid from xylose.
    Borja GM; Rodriguez A; Campbell K; Borodina I; Chen Y; Nielsen J
    Microb Cell Fact; 2019 Nov; 18(1):191. PubMed ID: 31690329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Introducing curcumin biosynthesis in Arabidopsis enhances lignocellulosic biomass processing.
    Oyarce P; De Meester B; Fonseca F; de Vries L; Goeminne G; Pallidis A; De Rycke R; Tsuji Y; Li Y; Van den Bosch S; Sels B; Ralph J; Vanholme R; Boerjan W
    Nat Plants; 2019 Feb; 5(2):225-237. PubMed ID: 30692678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. De novo biosynthesis of sakuranetin from glucose by engineered Saccharomyces cerevisiae.
    Tu S; Xiao F; Mei C; Li S; Qiao P; Huang Z; He Y; Gong Z; Zhong W
    Appl Microbiol Biotechnol; 2023 Jun; 107(12):3899-3909. PubMed ID: 37148336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De novo biosynthesis of p-coumaric acid and caffeic acid from carboxymethyl-cellulose by microbial co-culture strategy.
    Cai M; Liu J; Song X; Qi H; Li Y; Wu Z; Xu H; Qiao M
    Microb Cell Fact; 2022 May; 21(1):81. PubMed ID: 35538542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment of a yeast platform strain for production of p-coumaric acid through metabolic engineering of aromatic amino acid biosynthesis.
    Rodriguez A; Kildegaard KR; Li M; Borodina I; Nielsen J
    Metab Eng; 2015 Sep; 31():181-8. PubMed ID: 26292030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineering acetyl-CoA supply and ERG9 repression to enhance mevalonate production in Saccharomyces cerevisiae.
    Wegner SA; Chen JM; Ip SS; Zhang Y; Dugar D; Avalos JL
    J Ind Microbiol Biotechnol; 2021 Dec; 48(9-10):. PubMed ID: 34351398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. De novo production of the flavonoid naringenin in engineered Saccharomyces cerevisiae.
    Koopman F; Beekwilder J; Crimi B; van Houwelingen A; Hall RD; Bosch D; van Maris AJ; Pronk JT; Daran JM
    Microb Cell Fact; 2012 Dec; 11():155. PubMed ID: 23216753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.